Table 2.
Gene expression current study: Normalized copy number, ln transformed, mean and std dev for the 26 genes compared between shoulder and body wall implantation sites at 28 days.
GENE | 28 Day Gene Expression | |||
---|---|---|---|---|
Category | Name | Abbr. | Shoulder Xenograft Mean (SD) |
Body Wall Xenograft Mean (SD) |
Pro-inflammatory | Interleukin-1α | IL-1α | −8.66(4.51) | −9.50(4.34) |
Interleukin-1β | IL-1β | −6.93(3.49) | −7.24(4.15) | |
Interleukin-6 | IL-6 | −11.12(3.61) | −12.11(3.40) | |
Interleukin-8 | IL-8 | −13.99(3.40) | −15.13(2.41) | |
Interleukin-12β | IL-12β | −10.25(3.08) | −9.90(3.02) | |
Interleukin-18 | IL-18 | −7.02(4.55) | −6.80(4.16) | |
Interferon-γ | INFγ | −13.19(4.25) | −12.78(6.32) | |
inducible Nitric Oxide Synthase | iNOS | −6.81(3.30) | −6.51(3.48) | |
Tumor Necrosis Factor-α | TNFα | −10.13(4.86) | −9.73(2.58) | |
Pro-remodeling | Arginase | ARG | −13.96(3.12) | −14.11(3.07) |
Interleukin-1 receptor antagonist | IL-1ra | −5.52(2.86) | −4.85(3.64) | |
Interleukin-4 | IL-4 | −12.83(4.11) | −12.97(4.29) | |
Interleukin-5 | IL-5 | −18.21(4.80) | −17.06(3.87) | |
Interleukin-10 | IL-10 | −12.18(3.23) | −12.24(2.86) | |
Interleukin-13 | IL-13 | −13.00(3.32) | −12.58(3.40) | |
Transforming Growth Factor-β | TGF-β | −6.89(3.54) | −7.01(2.83) | |
ECM/Tendon | Decorin | DEC | −3.40(3.96) | −3.50(3.87) |
Collagen Type I | Col I | 1.18(3.72) | 0.15(3.92) | |
Collagen Type III | Col III | −8.09(3.84) | −7.95(3.35) | |
Thrombospondin-4 | TSP4 | −11.42(3.27) | −11.27(3.12) | |
Scleraxis | SCX | −10.36(3.99) | −11.54(4.36) | |
Tenomodulin | TND | −7.51(5.20) | −8.44(5.30) | |
Enzyme | Cathepsin K | Cat K | −6.33(3.87) | −4.85(4.54) |
Matrix Metalloproteinase-2 | MMP2 | −10.37(4.26) | −10.55(4.49) | |
Matrix Metalloproteinase-3 | MMP3 | −6.95(3.97) | −7.07(3.96) | |
Matrix Metalloproteinase-13 | MMP13 | −5.59(2.93) | −5.74(3.81) |